|Videos|June 2, 2017

How Can Behavioral Change Interventions Improve Antibiotic Prescribing?

Conan MacDougall, PharmD, discusses how behavioral change interventions can positively impact the antibiotic prescribing environment.

Conan MacDougall, PharmD, professor of clinical pharmacy, University of California, San Francisco, discusses how behavioral change interventions can positively impact the antibiotic prescribing environment.

Interview Transcript (slightly modified for readability)

“When you’re thinking about the effects of behavioral change, it’s important to think about both the effectiveness of different strategies and their efficiency. So, strategies like audited feedback that are typically used in antimicrobial stewardship are very effective, but they’re not necessarily efficient; they require a lot of manpower, a lot of time.

Other strategies that involve changing the antibiotic prescribing environment, what we might call ‘behavioral nudges,’ might be less effective on a per interaction basis, but can be scaled quickly using technology, so these might be things like changing antibiotic order entry set, or providing feedback to providers on how their antibiotic prescribing is similar to or different than other prescribers and how it meets institutional goals.”


Related to this article

How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
This Week's Top 5 Infectious Disease News Stories: September 12-September 18, 2026
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.